First Allied Advisory Services’s Pfizer PFE Stock Holding History

First Allied Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$8.84M	Sell	253,836 -7,575	-3%	-$266K	0.3%	73
2020 Q2	$8.11M	Buy	261,411 +3,761	+1%	+$128K	0.3%	78
2020 Q1	$7.98M	Buy	257,650 +11,433	+5%	+$390K	0.34%	59
2019 Q4	$9.21M	Buy	246,217 +7,019	+3%	+$250K	0.31%	71
2019 Q3	$8.22M	Sell	239,198 -26,345	-10%	-$958K	0.29%	74
2019 Q2	$10.9M	Sell	265,543 -7,992	-3%	-$317K	0.38%	51
2019 Q1	$11.1M	Buy	273,535 +2,126	+0.8%	+$85.1K	0.38%	53
2018 Q4	$11.3M	Sell	271,409 -20,053	-7%	-$832K	0.45%	47
2018 Q3	$12.2M	Buy	291,462 +6,018	+2%	+$232K	0.42%	41
2018 Q2	$9.9M	Sell	285,444 -12,881	-4%	-$440K	0.37%	50
2018 Q1	$10.1M	Sell	298,325 -3,352	-1%	-$115K	0.39%	45
2017 Q4	$10.4M	Buy	301,677 +3,007	+1%	+$103K	0.41%	42
2017 Q3	$10.2M	Sell	298,670 -12,023	-4%	-$386K	0.44%	44
2017 Q2	$10M	Buy	310,693 +11,446	+4%	+$361K	0.45%	42
2017 Q1	$9.73M	Buy	299,247 +5,234	+2%	+$165K	0.5%	43
2016 Q4	$9.06M	Buy	294,013 +17,021	+6%	+$520K	0.46%	46
2016 Q3	$8.9M	Sell	276,992 -26,168	-9%	-$875K	0.47%	43
2016 Q2	$10.2M	Sell	303,160 -5,264	-2%	-$168K	0.57%	35
2016 Q1	$8.75M	Sell	308,424 -6,603	-2%	-$189K	0.49%	38
2015 Q4	$9.72M	Sell	315,027 -31,649	-9%	-$996K	0.5%	43
2015 Q3	$10.4M	Sell	346,676 -36,194	-9%	-$1.16M	0.57%	27
2015 Q2	$12.3M	Buy	382,870 +221,924	+138%	+$7.23M	0.55%	28
2015 Q1	$5.31M	Buy	160,946 +19,864	+14%	+$632K	0.35%	57
2014 Q4	$4.17M	Buy	141,082 +10,209	+8%	+$293K	0.3%	73
2014 Q3	$3.68M	Sell	130,873 -109,064	-45%	-$3.06M	0.29%	77
2014 Q2	$6.83M	Sell	239,937 -8,218	-3%	-$234K	0.5%	36
2014 Q1	$7.61M	Buy	248,155 +33,657	+16%	+$1M	0.57%	24
2013 Q4	$6.28M	Sell	214,498 -115,173	-35%	-$3.35M	0.5%	27
2013 Q3	$9.02M	Buy	329,671 +73,565	+29%	+$2M	0.52%	39
2013 Q2	$6.86M	Buy	+256,106	New	+$7.08M	0.55%	28

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

First Allied Advisory Services's PFE Position: Q3 2020 in Review

First Allied Advisory Services reduced its Pfizer (PFE) stake by 2.9% in Q3 2020, selling an estimated $266K and leaving 253,836 shares worth $8.84M. The position accounts for 0.3% of the portfolio, ranked #73.

First Allied Advisory Services first reported a position in PFE in Q2 2013 and has held it in 30 quarters since. The position peaked at $12.3M in Q2 2015. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

First Allied Advisory Services held 253,836 shares of Pfizer worth $8.84M as of Q3 2020.
First Allied Advisory Services sold 7,575 Pfizer shares in Q3 2020, an estimated $266K.
Pfizer made up 0.3% of First Allied Advisory Services's portfolio in Q3 2020, its #73 holding.
First Allied Advisory Services first reported a position in Pfizer in Q2 2013 and has held it in 30 quarters since.
First Allied Advisory Services's Pfizer position peaked at $12.3M in Q2 2015.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.